Loading...
Loading...
Below are the top small-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next year.
Lannett Company
LCI is likely to earn $2.08 per share in the next year ending June, 2015. Lannett's trailing-twelve-month operating margin is 13.06%.
POZEN
POZN may earn $1.28 per share in the next year ending December, 2015. POZEN's PEG ratio is 0.43.
DepoMed
DEPO is projected to earn $0.51 per share for the next year ending December, 2015. DepoMed's trailing-twelve-month revenue is $120.19 million.
SciClone Pharmaceuticals
SCLN is expected to earn $0.45 per share over the next year ending December, 2015. SciClone Pharma's trailing-twelve-month ROE is 8.71%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in